Clinical Trial Update: A Phase 1 Study of Cizutamig in IgE Mediated Diseases [Phase 1]

View source ↗

Summary

Phase 1 trial update for Cizutamig by Candid Therapeutics for IgE-mediated hypersensitivity, IgE-mediated food allergy, and cow milk allergy; the study is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cow Milk Allergy
• Food Allergy

Drugs mentioned

• Cizutamig

Snippet

Sponsor: Candid Therapeutics | Conditions: IgE-Mediated Hypersensitivity, IgE Mediated Food Allergy | Phase 1 | Status: NOT_YET_RECRUITING